Neurofibromatosis 1 y cavernomatosis múltiple familiar en un lactante con sialorrea profusa episódica

Sánchez-Marco, Silvia B; Monge-Galindo, Lorena; López-Pisón, Javier; García-Jiménez, Inmaculada; Peña-Segura, José L; López-Lafuente, Amparo.
Rev. neurol. (Ed. impr.) ; 69(8): 350-352, 16 oct., 2019.
Artículo en Español | IBECS (España) | ID: ibc-187095

Documentos relacionados

  1. NEUROFIBROMATOSIS TYPE I AND ITS DIAGNOSTIC CRITERIA: A CLINICAL OBSERVATION.
  2. Neurofibromatosis type 1 system-based manifestations and treatments: a review.
  3. High-yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing.
  4. Evaluation of the impact of the 2021 revised Neurofibromatosis type 1 diagnostic criteria on time to diagnosis.
  5. Structural basis of activation of the tumor suppressor protein neurofibromin.
  6. Novel germinal mutation in NF1: case report.
  7. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
  8. Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature.
  9. Management of neurofibromatosis type 1 associated tumors of central and peripheral nervous system.
  10. Novel, heterozygous, pathogenic variant (c.4272delA: p.I1426Ffs*2) for the NF1 gene in a large Chinese family with neurofibromatosis type 1.